• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用多价噬菌体来对抗导致导管相关性尿路感染的奇异变形杆菌生物膜。

Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.

机构信息

Department of Biology of Bacteria, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.

出版信息

J Appl Microbiol. 2018 Nov;125(5):1253-1265. doi: 10.1111/jam.14026. Epub 2018 Jul 18.

DOI:10.1111/jam.14026
PMID:29924909
Abstract

AIMS

Catheter-associated urinary tract infections (CAUTI) caused by Proteus mirabilis are very difficult to treat due to the ability of biofilm formation and drug resistance of these bacteria. The aim of this study was to assess the antibiofilm activity of phages and develop phage cocktail to combat biofilm of P. mirabilis strains.

METHODS AND RESULTS

Planktonic forms and biofilms of 50 tested uropathogenic P. mirabilis strains showed different sensitivity to 13 phages used. Phages 39APmC32, 65APm2833 and 72APm5211 presenting strong antibiofilm activity were selected as cocktail components. The antibiofilm activity of phage cocktails was similar or slightly higher than that of the most active phage. A three-phage cocktail inhibited biofilm formation and destroyed biofilms of the same number of strains or 2-3 strains more compared to a single phage. The components of the three-phage cocktail did not block each other's activity.

CONCLUSIONS

The potential of developed anti-P. mirabilis phage cocktail as an antibiofilm agent was proved.

SIGNIFICANCE AND IMPACT OF THE STUDY

In this study, three broad host range phages presenting strong anti-P. mirabilis biofilm activity were selected. Additionally, high stability of these viruses makes them a useful tool for controlling the biofilms.

摘要

目的

由于生物膜形成能力和这些细菌的耐药性,奇异变形杆菌引起的导管相关尿路感染(CAUTI)非常难以治疗。本研究旨在评估噬菌体的抗生物膜活性,并开发噬菌体鸡尾酒来对抗奇异变形杆菌菌株的生物膜。

方法和结果

50 株测试的尿路致病性奇异变形杆菌浮游形式和生物膜对使用的 13 种噬菌体表现出不同的敏感性。噬菌体 39APmC32、65APm2833 和 72APm5211 表现出强烈的抗生物膜活性,被选为鸡尾酒成分。噬菌体鸡尾酒的抗生物膜活性与最活跃的噬菌体相似或略高。三噬菌体鸡尾酒抑制生物膜形成并破坏相同数量的菌株或比单个噬菌体多 2-3 株的生物膜。三种噬菌体鸡尾酒的成分不会相互阻断彼此的活性。

结论

所开发的抗奇异变形杆菌噬菌体鸡尾酒作为抗生物膜剂的潜力已得到证明。

研究的意义和影响

在这项研究中,选择了三种具有广泛宿主范围且对奇异变形杆菌具有强烈抗生物膜活性的噬菌体。此外,这些病毒的高稳定性使它们成为控制生物膜的有用工具。

相似文献

1
Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.使用多价噬菌体来对抗导致导管相关性尿路感染的奇异变形杆菌生物膜。
J Appl Microbiol. 2018 Nov;125(5):1253-1265. doi: 10.1111/jam.14026. Epub 2018 Jul 18.
2
A Phage Cocktail To Control Surface Colonization by Proteus mirabilis in Catheter-Associated Urinary Tract Infections.噬菌体鸡尾酒控制导管相关尿路感染中奇异变形杆菌的表面定植。
Microbiol Spectr. 2022 Oct 26;10(5):e0209222. doi: 10.1128/spectrum.02092-22. Epub 2022 Oct 4.
3
Differentiation of polyvalent bacteriophages specific to uropathogenic Proteus mirabilis strains based on the host range pattern and RFLP.基于宿主范围模式和限制性片段长度多态性对奇异变形杆菌致病性菌株特异性多价噬菌体的鉴别
Acta Biochim Pol. 2016;63(2):303-10. doi: 10.18388/abp.2015_1114. Epub 2016 Jan 7.
4
Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages.利用噬菌体消除多药耐药奇异变形杆菌生物膜。
Arch Virol. 2019 Sep;164(9):2265-2275. doi: 10.1007/s00705-019-04305-x. Epub 2019 Jun 14.
5
Isolation and Characterization of a Lytic Bacteriophage (vB_PmiS-TH) and Its Application in Combination with Ampicillin against Planktonic and Biofilm Forms of Proteus mirabilis Isolated from Urinary Tract Infection.一种裂解性噬菌体(vB_PmiS-TH)的分离、鉴定及其与氨苄西林联合应用对从尿路感染分离出的奇异变形杆菌浮游菌和生物被膜形式的作用
J Mol Microbiol Biotechnol. 2018;28(1):37-46. doi: 10.1159/000487137. Epub 2018 Apr 4.
6
Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.过氧化氢酶活性对于奇异变形杆菌生物膜的形成、胞外聚合物质的组成以及在与导管相关的尿路感染期间的传播至关重要。
Infect Immun. 2021 Sep 16;89(10):e0017721. doi: 10.1128/IAI.00177-21. Epub 2021 Jul 19.
7
Efficacy of three lytic bacteriophages for eradicating biofilms of multidrug-resistant Proteus mirabilis.三种裂解噬菌体清除多药耐药奇异变形杆菌生物膜的效果。
Arch Virol. 2021 Dec;166(12):3311-3322. doi: 10.1007/s00705-021-05241-5. Epub 2021 Sep 24.
8
Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.在体外导尿管模型中,噬菌体介导对由引起导管相关尿路感染的微生物形成的双物种生物膜的控制。
Antimicrob Agents Chemother. 2015 Feb;59(2):1127-37. doi: 10.1128/AAC.03786-14. Epub 2014 Dec 8.
9
The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms.奇异变形杆菌对头孢他啶和环丙沙星敏感性的评估以及这些抗生素在亚抑菌浓度下对奇异变形杆菌生物膜的影响。
Biomed Res Int. 2013;2013:930876. doi: 10.1155/2013/930876. Epub 2013 Sep 12.
10
Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections.一种用于控制奇异变形杆菌导管相关尿路感染的噬菌体鸡尾酒疗法的研发。
Front Microbiol. 2016 Jun 28;7:1024. doi: 10.3389/fmicb.2016.01024. eCollection 2016.

引用本文的文献

1
Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infections.噬菌体疗法治疗胃肠道相关感染所面临挑战的最新见解。
Gut Pathog. 2025 Aug 11;17(1):60. doi: 10.1186/s13099-025-00735-y.
2
Lytic bacteriophages as alternative to overcoming antibiotic-resistant biofilms formed by clinically significant bacteria.裂解性噬菌体作为克服由具有临床意义的细菌形成的抗生素抗性生物膜的替代方法。
Ther Adv Infect Dis. 2025 Jul 18;12:20499361251356057. doi: 10.1177/20499361251356057. eCollection 2025 Jan-Dec.
3
The rise, fall, and resurgence of phage therapy for urinary tract infection.
用于治疗尿路感染的噬菌体疗法的兴衰与复兴
EcoSal Plus. 2024 Dec 12;12(1):eesp00292023. doi: 10.1128/ecosalplus.esp-0029-2023. Epub 2024 Jan 11.
4
A New Approach for Phage Cocktail Design in the Example of Anti-Mastitis Solution.以抗乳腺炎解决方案为例的噬菌体鸡尾酒设计新方法。
Pathogens. 2024 Sep 27;13(10):839. doi: 10.3390/pathogens13100839.
5
Bacteriophage P2-71: a promising therapeutic against multidrug-resistant in urinary tract infections.噬菌体P2-71:一种治疗多重耐药性尿路感染的有前景的疗法。
Front Vet Sci. 2024 Sep 17;11:1445264. doi: 10.3389/fvets.2024.1445264. eCollection 2024.
6
Non-Antibiotic Prevention of Catheter Mechanic and Septic Complications in Patients with Long-Term Indwelling Catheters: a Crossover Prospective Study Involving L-Methionine.长期留置导管患者导管机械性和感染性并发症的非抗生素预防:一项涉及L-蛋氨酸的交叉前瞻性研究。
Maedica (Bucur). 2024 Jun;19(2):212-220. doi: 10.26574/maedica.2024.19.2.212.
7
Serratia marcescens ATCC 274 increases production of the red pigment prodigiosin in response to Chi phage infection.粘质沙雷氏菌ATCC 274在受到Chi噬菌体感染时会增加红色色素灵菌红素的产量。
Sci Rep. 2024 Jul 31;14(1):17750. doi: 10.1038/s41598-024-68747-3.
8
Does Phage Therapy Need a Pan-Phage?噬菌体疗法需要通用噬菌体吗?
Pathogens. 2024 Jun 20;13(6):522. doi: 10.3390/pathogens13060522.
9
Medical Device-Associated Biofilm Infections and Multidrug-Resistant Pathogens.医疗器械相关生物膜感染与多重耐药病原体
Pathogens. 2024 May 8;13(5):393. doi: 10.3390/pathogens13050393.
10
Anti-Biofilm Strategies: A Focused Review on Innovative Approaches.抗生物膜策略:创新方法聚焦综述
Microorganisms. 2024 Mar 22;12(4):639. doi: 10.3390/microorganisms12040639.